Document Detail
Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery disease: the INternational VErapamil SR-Trandolapril STudy (INVEST)
Abstract/OtherAbstract :
Mancia, G; Keltai, M; Erdine, S; Hewkin, A; Kupfer, S; Pepine, CJ, 6, Titolo del supplemento: Abstracts selected for presentation at the European Society of Cardiology Congress 28 August - 1 September 2004, Munich (Germany)
Authors :
MANCIA, GIUSEPPE (7298)
Contributors :
-
Publication Detail :
Publisher :  W B SAUNDERS CO LTD, LONDON     Type :  Articolo su rivista, Rilevanza internazionale, Articolo, Con referee, Con Impact Factor ISI, Pubblicato     Format :  -    
Date Detail :
2008-08-28, 2008-08-28, 2004-08
Subject :
Coronary heart disease, CV risk, Settore MED/09 - Medicina Interna (1451)
Coverage :
-
Relation :
EUROPEAN HEART JOURNAL, 25, suppl. 1, 423, 424, 0195-668X
Source :
-
Copyright Information :
-
Other Details :
Languages :  eng    
Export Citation :
APA/MLA Format     Download EndNote     Download BibTex

Previous Document:  New-onset diabetes and anti hypertensive drugs
Next Document:  Acute liver CCl4 intoxication causes low HSP70 gene expression and a delayed transition through the ...